Wasehuus V, Smeijer JD, Ambery P, Greasley PJ, et al. Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease. Diabetes Obes Metab 2025 May 21. doi: 10.1111/dom.16468.
PMID: 40396470